Commentary

Article

State of the Science Summit - Lung Cancer: Chaired by Edward Garon, MD, MS

In Partnership With:

State of the Science Summit - Lung Cancer: Chaired by Edward Garon, MD, MS

State of the Science Summit - Lung Cancer: Chaired by Edward Garon, MD, MS

Speakers

  • Edward Garon, MD, MS | UCLA Health Jonsson Comprehensive Cancer Center
  • Karen Reckamp, MD | Cedars-Sinai Cancer
  • Jonathan Goldman, MD | UCLA Health Jonsson Comprehensive Cancer Center
  • Jay Lee, MD | UCLA Health Jonsson Comprehensive Cancer Center

Topics

  • Exploring Targeted Therapies in NSCLC
  • Targeting EGFR-Mutant NSCLC
  • Antibody-Drug Conjugates in NSCLC
  • Perioperative Strategies in NSCLC
  • Treatment Crossroads: Application of Data

Interested in attending a live or virtual event? Click here to register for an upcoming webinar.

Some of the episodes from our podcast, OncLive On Air, are focused on the interviews with faculty conducted at the State of the Science Summits. Click here to listen to our latest episodes!

Related Videos
Taofeek Owonikoko, MD, PhD
Suresh S. Ramalingam, MD, FACP, FASCO
Intracranial Efficacy of Datopotamab Deruxtecan in Patients with Previously Treated Advanced/Metastatic Non-Small Cell Lung Cancer with Actionable Genomic Alterations: Results from Tropion-Lung05
4 KOLs are featured in this series
4 KOLs are featured in this series
John Heymach, MD, PhD
Subcutaneous amivantamab vs intravenous amivantamab, both in combination with lazertinib, in refractory EGFR-mutated, advanced non-small cell lung cancer (NSCLC): Primary results, including overall survival (OS), from the global, phase 3, randomized controlled PALOMA-3 trial
5 KOLs are featured in this peer exchange
5 KOLs are featured in this peer exchange
A panel of 5 experts on breast cancer
Related Content
OncLive On Air® 
July 1st 2024

Revisit Every OncLive On Air Episode From June 2024

Stephen Liu, MD; Sara A. Hurvitz, MD, FACP; S. Vincent Rajkumar, MD; Sumanta Kumar Pal, MD, FASCO; Shubham Pant, MD, MBBS
May 23rd 2024

Oncology Experts Preview Top Abstracts From the 2024 ASCO Annual Meeting

State of the Science Summit - Breast Cancer: Chaired by Paolo Tarantino, MD, and Sara Tolaney, MD, MPH
June 27th 2024

State of the Science Summit - Breast Cancer: Chaired by Paolo Tarantino, MD, and Sara Tolaney, MD, MPH

Stephanie L. Graff, MD, director, Breast Oncology, Lifespan Cancer Institute, associate professor, medicine, Brown University; Reshma L. Mahtani, DO, medical oncologist, Miami Cancer Institute, chief, Breast Medical Oncology, Baptist Health’s Wellness and Medical Complex; Kelly E. McCann, MD, PhD, breast medical oncologist, assistant clinical professor, medicine, the University of California, Los Angeles Health David Geffen School of Medicine; Hope S. Rugo, MD, Winterhof Family Endowed Professor in Breast Cancer, the University of California San Francisco (UCSF), professor, medicine, Division of Hematology and Oncology, director, Breast Oncology, director, Clinical Trials Education, director, Cancer Infusion Services, the UCSF Helen Diller Family Comprehensive Cancer Center
April 11th 2024

Breast Cancer Experts Share Obstacles and Successes as Women in Oncology

Dave Fredrickson
June 25th 2024

First-Line Osimertinib Plus Chemo Approved in Japan for EGFR+ Advanced NSCLC

Susan Galbraith
June 25th 2024

Adjuvant Durvalumab Misses DFS End Point in Resected, PD-L1+ Stage IB-IIIA NSCLC